Interaction of levodopa and cues on voluntary reaching in Parkinson's disease
Identifieur interne : 004427 ( Main/Exploration ); précédent : 004426; suivant : 004428Interaction of levodopa and cues on voluntary reaching in Parkinson's disease
Auteurs : Valerie E. Kelly [États-Unis] ; Allie S. Hyngstrom [États-Unis] ; Melissa M. Rundle [États-Unis] ; Amy J. Bastian [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2002-01.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Personne âgée.
English descriptors
- KwdEn :
- Antiparkinson Agents (pharmacology), Antiparkinson Agents (therapeutic use), Antiparkinson agent, Body movement, Chemotherapy, Cues, Elderly, Female, Humans, Hypokinesia (diagnosis), Hypokinesia (etiology), Kinematics, Levodopa, Levodopa (therapeutic use), Light stimulus, Male, Middle Aged, Parkinson Disease (complications), Parkinson Disease (drug therapy), Parkinson disease, Parkinson's disease, Performance evaluation, Reachability, Severity of Illness Index, Treatment, bradykinesia, external cues, levodopa, movement.
- MESH :
- chemical , pharmacology : Antiparkinson Agents.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- complications : Parkinson Disease.
- diagnosis : Hypokinesia.
- drug therapy : Parkinson Disease.
- etiology : Hypokinesia.
- Cues, Female, Humans, Male, Middle Aged, Severity of Illness Index.
Abstract
The bradykinesia associated with Parkinson's disease (PD) can be improved by both levodopa and the use of external cues. We examined the combined effect of levodopa and external cueing on the voluntary reaching movements of individuals with PD. Nine subjects with PD and nine matched controls were studied reaching to a ball target. Subjects with PD were studied after being off levodopa overnight and again on their morning dose. Kinematic data were collected as all subjects made both accurate and fast reaches under two different cue conditions: noncued (self‐initiated) and cued (triggered by a light). Subjects with PD reached more slowly than controls under all conditions. PD subjects increased their reach velocity and decreased movement time after taking levodopa and also when moving to a cue. However, the effects of levodopa and cueing were not additive. Instead, levodopa improved reach velocity to a greater extent in the noncued vs. cued condition. We also found that levodopa improved accurate (self‐paced) reaches more than fast reaches. These data suggest that levodopa may preferentially improve voluntary reaches that are more internally generated. © 2002 Movement Disorder Society.
Url:
DOI: 10.1002/mds.10000
Affiliations:
- États-Unis
- Missouri (État)
- Saint-Louis (Missouri)
- École de médecine (Université Washington de Saint-Louis)
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001F48
- to stream Istex, to step Curation: 001F48
- to stream Istex, to step Checkpoint: 002D18
- to stream Main, to step Merge: 006432
- to stream PascalFrancis, to step Corpus: 002824
- to stream PascalFrancis, to step Curation: 000497
- to stream PascalFrancis, to step Checkpoint: 002727
- to stream Main, to step Merge: 006766
- to stream PubMed, to step Corpus: 003C01
- to stream PubMed, to step Curation: 003C01
- to stream PubMed, to step Checkpoint: 003A58
- to stream Ncbi, to step Merge: 000650
- to stream Ncbi, to step Curation: 000650
- to stream Ncbi, to step Checkpoint: 000650
- to stream Main, to step Merge: 006185
- to stream Main, to step Curation: 004427
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Interaction of levodopa and cues on voluntary reaching in Parkinson's disease</title>
<author><name sortKey="Kelly, Valerie E" sort="Kelly, Valerie E" uniqKey="Kelly V" first="Valerie E." last="Kelly">Valerie E. Kelly</name>
</author>
<author><name sortKey="Hyngstrom, Allie S" sort="Hyngstrom, Allie S" uniqKey="Hyngstrom A" first="Allie S." last="Hyngstrom">Allie S. Hyngstrom</name>
</author>
<author><name sortKey="Rundle, Melissa M" sort="Rundle, Melissa M" uniqKey="Rundle M" first="Melissa M." last="Rundle">Melissa M. Rundle</name>
</author>
<author><name sortKey="Bastian, Amy J" sort="Bastian, Amy J" uniqKey="Bastian A" first="Amy J." last="Bastian">Amy J. Bastian</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:597EDDD10BB7D74FDD91A0CF196FF2747FB0A6C2</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.10000</idno>
<idno type="url">https://api.istex.fr/document/597EDDD10BB7D74FDD91A0CF196FF2747FB0A6C2/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001F48</idno>
<idno type="wicri:Area/Istex/Curation">001F48</idno>
<idno type="wicri:Area/Istex/Checkpoint">002D18</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Kelly V:interaction:of:levodopa</idno>
<idno type="wicri:Area/Main/Merge">006432</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:02-0206587</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002824</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000497</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002727</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Kelly V:interaction:of:levodopa</idno>
<idno type="wicri:Area/Main/Merge">006766</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:11835437</idno>
<idno type="wicri:Area/PubMed/Corpus">003C01</idno>
<idno type="wicri:Area/PubMed/Curation">003C01</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003A58</idno>
<idno type="wicri:Area/Ncbi/Merge">000650</idno>
<idno type="wicri:Area/Ncbi/Curation">000650</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000650</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Kelly V:interaction:of:levodopa</idno>
<idno type="wicri:Area/Main/Merge">006185</idno>
<idno type="wicri:Area/Main/Curation">004427</idno>
<idno type="wicri:Area/Main/Exploration">004427</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Interaction of levodopa and cues on voluntary reaching in Parkinson's disease</title>
<author><name sortKey="Kelly, Valerie E" sort="Kelly, Valerie E" uniqKey="Kelly V" first="Valerie E." last="Kelly">Valerie E. Kelly</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Program in Physical Therapy, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
</author>
<author><name sortKey="Hyngstrom, Allie S" sort="Hyngstrom, Allie S" uniqKey="Hyngstrom A" first="Allie S." last="Hyngstrom">Allie S. Hyngstrom</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Program in Physical Therapy, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
</author>
<author><name sortKey="Rundle, Melissa M" sort="Rundle, Melissa M" uniqKey="Rundle M" first="Melissa M." last="Rundle">Melissa M. Rundle</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Movement Disorders Center, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
</author>
<author><name sortKey="Bastian, Amy J" sort="Bastian, Amy J" uniqKey="Bastian A" first="Amy J." last="Bastian">Amy J. Bastian</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Program in Physical Therapy, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Movement Disorders Center, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-01">2002-01</date>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="38">38</biblScope>
<biblScope unit="page" to="44">44</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">597EDDD10BB7D74FDD91A0CF196FF2747FB0A6C2</idno>
<idno type="DOI">10.1002/mds.10000</idno>
<idno type="ArticleID">MDS10000</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Antiparkinson agent</term>
<term>Body movement</term>
<term>Chemotherapy</term>
<term>Cues</term>
<term>Elderly</term>
<term>Female</term>
<term>Humans</term>
<term>Hypokinesia (diagnosis)</term>
<term>Hypokinesia (etiology)</term>
<term>Kinematics</term>
<term>Levodopa</term>
<term>Levodopa (therapeutic use)</term>
<term>Light stimulus</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Performance evaluation</term>
<term>Reachability</term>
<term>Severity of Illness Index</term>
<term>Treatment</term>
<term>bradykinesia</term>
<term>external cues</term>
<term>levodopa</term>
<term>movement</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiparkinson Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Hypokinesia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hypokinesia</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cues</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antiparkinsonien</term>
<term>Atteignabilité</term>
<term>Bradykinésie</term>
<term>Chimiothérapie</term>
<term>Cinématique</term>
<term>Evaluation performance</term>
<term>Lévodopa</term>
<term>Mouvement corporel</term>
<term>Parkinson maladie</term>
<term>Personne âgée</term>
<term>Stimulus lumineux</term>
<term>Traitement</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Personne âgée</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The bradykinesia associated with Parkinson's disease (PD) can be improved by both levodopa and the use of external cues. We examined the combined effect of levodopa and external cueing on the voluntary reaching movements of individuals with PD. Nine subjects with PD and nine matched controls were studied reaching to a ball target. Subjects with PD were studied after being off levodopa overnight and again on their morning dose. Kinematic data were collected as all subjects made both accurate and fast reaches under two different cue conditions: noncued (self‐initiated) and cued (triggered by a light). Subjects with PD reached more slowly than controls under all conditions. PD subjects increased their reach velocity and decreased movement time after taking levodopa and also when moving to a cue. However, the effects of levodopa and cueing were not additive. Instead, levodopa improved reach velocity to a greater extent in the noncued vs. cued condition. We also found that levodopa improved accurate (self‐paced) reaches more than fast reaches. These data suggest that levodopa may preferentially improve voluntary reaches that are more internally generated. © 2002 Movement Disorder Society.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Missouri (État)</li>
</region>
<settlement><li>Saint-Louis (Missouri)</li>
</settlement>
<orgName><li>École de médecine (Université Washington de Saint-Louis)</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Missouri (État)"><name sortKey="Kelly, Valerie E" sort="Kelly, Valerie E" uniqKey="Kelly V" first="Valerie E." last="Kelly">Valerie E. Kelly</name>
</region>
<name sortKey="Bastian, Amy J" sort="Bastian, Amy J" uniqKey="Bastian A" first="Amy J." last="Bastian">Amy J. Bastian</name>
<name sortKey="Bastian, Amy J" sort="Bastian, Amy J" uniqKey="Bastian A" first="Amy J." last="Bastian">Amy J. Bastian</name>
<name sortKey="Bastian, Amy J" sort="Bastian, Amy J" uniqKey="Bastian A" first="Amy J." last="Bastian">Amy J. Bastian</name>
<name sortKey="Hyngstrom, Allie S" sort="Hyngstrom, Allie S" uniqKey="Hyngstrom A" first="Allie S." last="Hyngstrom">Allie S. Hyngstrom</name>
<name sortKey="Rundle, Melissa M" sort="Rundle, Melissa M" uniqKey="Rundle M" first="Melissa M." last="Rundle">Melissa M. Rundle</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004427 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004427 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:597EDDD10BB7D74FDD91A0CF196FF2747FB0A6C2 |texte= Interaction of levodopa and cues on voluntary reaching in Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |